For comments, suggestions
Created with Raphaël 2.1.0 13.04.2016 Filing date 13.11.2017 Validation fee payment 30.04.2018 (A1) Patent application published 02.01.2026 Can request protection in MD until

Patent not validated (the request for validation was not submitted on time)


(210)Number of the EPO application16780054
(220)Filing date of the EPO application2016.04.13
(80)EPO patent specification publication (B)EPB nr. 27/2025, 2025.07.02
(110)EPO patent number3284480
(21)Number of the applicatione 2018 0192
(71)Name(s) of applicant(s), code of the countryCHUGAI SEIYAKU KABUSHIKI KAISHA, JP;
(72)Name(s) of inventor(s), code of the countryKANEKO Akihisa, JP;
IWAYANAGI Yuki, JP;
KITAMURA Hidetomo, JP;
HIGUCHI Yoshinobu, JP;
MATSUSHITA Hiroaki, JP;
MIHARA Ryosuke, JP;
YAMAMOTO Yumi, JP;
SAITO Tomohisa, JP;
HIROKAWA Keiko, JP;
(73)Name(s) of owner(s), code of the countryCHUGAI SEIYAKU KABUSHIKI KAISHA, JP;
(54)Title of the inventionPHARMACEUTICAL COMPOSITION FOR PREVENTION AND/OR TREATMENT OF ATOPIC DERMATITIS CONTAINING IL-31 ANTAGONIST AS ACTIVE INGREDIENT
(13)Kind-of-document code A1
(51)International Patent Classification A61K 45/00 (2006.01.01); A61K 39/395 (2006.01.01); A61P 17/00 (2006.01.01); A61P 17/04 (2006.01.01); A61P 25/20 (2006.01.01); C07K 16/24 (2006.01.01); C07K 16/28 (2006.01.01)
(52)Cooperative Patent Classification A61P 17/00 (EP); A61K 39/3955 (EP); C07K 16/244 (EP); A61K 2039/505 (EP); A61K 2039/545 (EP); C07K 2317/52 (EP); C07K 2317/526 (EP); C07K 2317/565 (EP); C07K 2317/76 (EP); C07K 2317/94 (EP)
(19)CountryJP
(41)Date of publication of the application2018.04.30
(30)Priority2015082699, 2015.04.14, JP; 2016041641, 2016.03.04, JP
(86)International applicationPCT/JP2016/061859, 2016.04.13
(87)International publicationWO 2016/167263, 2016.10.20
Up
/Inventions/details/3284480